Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
225.6 USD | +4.35% |
|
+11.90% | -4.45% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.45% | 11.14B | |
+24.77% | 46.56B | |
+45.38% | 41.67B | |
+0.17% | 41.16B | |
+33.18% | 32.4B | |
+21.03% | 28.18B | |
-6.35% | 28.1B | |
+49.05% | 14.52B | |
+47.23% | 13.74B | |
+3.21% | 12.17B |
- Stock Market
- Equities
- CRL Stock
- News Charles River Laboratories International, Inc.
- Stephens Adjusts Price Target on Charles River Laboratories International to $250 From $280